Tobias V Lanz

19PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 10, 2026
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.

|Mar 12, 2026
Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonist.

Qinli Sun, Alison K Barrett, Masato Ogishi

|Mar 06, 2026
Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosis.

Fok Moon Lum, Neda Sattarnezhad, Peggy P Ho

|Feb 23, 2026
EBV reprograms autoreactive anti-CNS B cells as antigen presenting cells in multiple sclerosis.

Shady Younis, Sajede Rasouli, Jacob W Loeffler

|Nov 29, 2025
Development of ACE2-tropic-betacoronavirus therapeutics for future pandemic preparedness.

Ashley Utz, Matt Armbrust, Thuy-Tien T Nguyen

|Nov 12, 2025
Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus.

Shady Younis, Salvinaz I Moutusy, Sajede Rasouli

Pageof 4

Frequent Collaborators

12 joint publications

William H Robinson

5 joint publications

Lawrence Steinman

3 joint publications

Peggy P Ho

3 joint publications

Shaghayegh Jahanbani